Inventors with similar research interests:
Company Filing History:
117 out of 10,754 
1 out of 5,674 
1 out of 52 
Years Active: 1976-2011
Areas of Expertise:
Title: Axel Sanner: A Prolific Innovator in Pharmaceutical Excipients
Introduction:
In the realm of pharmaceutical innovations, Axel Sanner stands out as a prolific inventor and researcher based in Frankenthal, Germany. With an impressive collection of 120 patents to his name, Sanner's contribution to the field of pharmaceutical excipients has been phenomenal. This article provides an insight into his latest patents, highlights of his career, notable collaborations, and his overall impact on the industry.
Latest Patents:
Axel Sanner's recent patents demonstrate his commitment to enhancing solid pharmaceutical presentations. One notable invention includes solubilizing aids in powder form for solid pharmaceutical presentation forms. This patent focuses on the development of excipients comprising a pharmaceutically acceptable polymer and a solubilizing surface-active substance, providing improved drug delivery options.
Another significant patent involves the use of copolymers of carboxylic acids and long-chain compounds as thickeners or dispersants. This invention explores the application of copolymers in cosmetic and pharmaceutical preparations, particularly for their thickening and dispersing properties. By leveraging various compounds and monomers, Sanner aims to enhance the quality and efficacy of such preparations.
Career Highlights:
Throughout his career, Axel Sanner has made remarkable contributions while working at notable companies such as BASF Aktiengesellschaft. His extensive patent portfolio showcases his deep understanding of pharmaceutical excipients, solidifying his position as an industry expert. Sanner's dedication to innovation and research has undoubtedly shaped the field, establishing him as a respected figure.
Collaborations:
Axel Sanner has had the opportunity to collaborate with talented professionals in his field. Notably, he has worked alongside colleagues such as Son Nguyen Kim and Volker Schehlmann. These collaborations have undoubtedly fostered knowledge exchange, synergy, and the development of groundbreaking solutions in pharmaceutical excipients.
Conclusion:
Axel Sanner's remarkable journey in the field of pharmaceutical excipients highlights his commitment to innovation and scientific exploration. With an impressive collection of patents to his name, Sanner has undoubtedly shaped the industry and contributed significantly to drug delivery advancements. His expertise and collaborations have undoubtedly paved the way for future developments in pharmaceutical formulations. As the industry continues to evolve, Axel Sanner's contributions will undoubtedly inspire and guide future innovators in the field of pharmaceutical excipients.